Codexis (CDXS) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Codexis (CDXS) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 29.47% |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 74.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.90% |
| Dec 31, 2025 | 97.44% |
| Sep 30, 2025 | 92.14% |
| Jun 30, 2025 | -93.71% |
| Mar 31, 2025 | -27.38% |
| Dec 31, 2024 | 14.39% |
| Sep 30, 2024 | -606.33% |
| Jun 30, 2024 | -428.90% |
| Mar 31, 2024 | -4.88% |
| Dec 31, 2023 | 92.22% |
| Sep 30, 2023 | -211.21% |
| Jun 30, 2023 | 67.99% |
| Mar 31, 2023 | 17.15% |
| Dec 31, 2022 | -93.04% |
| Sep 30, 2022 | -3,166.14% |
| Jun 30, 2022 | 36.87% |
| Mar 31, 2022 | -8.34% |
| Dec 31, 2021 | 29.36% |
| Sep 30, 2021 | 26.01% |
| Jun 30, 2021 | 90.71% |